EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cardioprotective and Anti‐Hypertensive Effects of Epigallocatechin Gallate: Novel Insights Into Biological Evidence

Reza Eshraghi, Ashkan Bahrami, Faraz Tayyar Iravanlou, Mehdi Karimi iD, Mohammad Saeed Soleimani, Mohammad Hossein Paknahad, Mohammad Yaghoubi, Arman Beheshtirooy, Fatemeh Qasemi Talouki, Javad Shaabanzadeh iD, Fatemeh Hasani, Alireza Rafi und 1 weitere

The Journal of Clinical Hypertension · 2025-06 · 27 (6)

DOI: 10.1111/jch.70036 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Hypertension, online erschienen am 10.06.2025. Verfasst von Reza Eshraghi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran. Hauptthemen laut MEDLINE: Catechin, Hypertension, Antihypertensive Agents, Cardiotonic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigallocatechin gallate (EGCG), the major catechin in green tea, is of considerable interest principally due to its proposed antihypertensive and cardioprotective properties. New research shows that EGCG can help relax the circulation of blood vessels, reduce arterial stiffness of arteries, and promote antioxidant activity promotion, which results in lowering blood pressure (BP) and better‐improving heart health. It also affects signaling pathways related to nitric oxide (NO) production, inflammation, and oxidative stress, which are crucial for vascular homeostasis. Although animal research and clinical trials demonstrate that regular intake of EGCG significantly decreases BP and improves lipid profiles, further studies are needed to confirm these benefits in diverse populations. This review highlights the relevant biological data supporting these effects and the mechanisms by which EGCG impacts cardiovascular health. This review provides a new perspective on the many favorable effects of EGCG, such as its potential role in cardiovascular disease prevention, essential hypertension (HTN), and atherosclerosis. These results point to the need for more clinical trials aimed at determining whether EGCG may be used as a natural approach to reducing HTN and its cardiovascular complications through dietary interventions to enhance public health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CatechinHypertensionAntihypertensive AgentsCardiotonic AgentsHumansAnimalsBlood PressureAntioxidantsCardiovascular DiseasesOxidative StressTea

Stichwörter der Autor:innen

cardioprotectivecardiovascularepigallocatechingreen teaherbal medicinehypertensionphytotherapy

Substanzen

Catechinepigallocatechin gallateAntihypertensive AgentsCardiotonic AgentsAntioxidantsTea

Autor:innen und Institutionen

  • Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
  • Department of Psychiatric Nursing, School of Nursing and Midwifery, Urmia University of Medical Sciences, Urmia, Iran.
  • Faculty of Medicine, Bogomolets National Medical University (NMU), Kyiv, Ukraine.
  • Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
  • Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Research Center Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

ORCID-Profile: Mehdi Karimi, Javad Shaabanzadeh

Zitieren

APA

Eshraghi, R., Bahrami, A., Iravanlou, F. T., Karimi, M., Soleimani, M. S., Paknahad, M. H., Yaghoubi, M., Beheshtirooy, A., Talouki, F. Q., Shaabanzadeh, J., Hasani, F., Rafi, A., & Pourhanifeh, M. H. (2025). Cardioprotective and Anti‐Hypertensive Effects of Epigallocatechin Gallate: Novel Insights Into Biological Evidence. The Journal of Clinical Hypertension, 27(6). https://doi.org/10.1111/jch.70036

Vancouver

Eshraghi R, Bahrami A, Iravanlou FT, Karimi M, Soleimani MS, Paknahad MH, et al. Cardioprotective and Anti‐Hypertensive Effects of Epigallocatechin Gallate: Novel Insights Into Biological Evidence. The Journal of Clinical Hypertension. 2025;27(6). doi:10.1111/jch.70036

BibTeX
@article{Eshraghi2025,
  author = {Eshraghi, Reza and Bahrami, Ashkan and Iravanlou, Faraz Tayyar and Karimi, Mehdi and Soleimani, Mohammad Saeed and Paknahad, Mohammad Hossein and Yaghoubi, Mohammad and Beheshtirooy, Arman and Talouki, Fatemeh Qasemi and Shaabanzadeh, Javad and Hasani, Fatemeh and Rafi, Alireza and Pourhanifeh, Mohammad Hossein},
  title = {Cardioprotective and Anti‐Hypertensive Effects of Epigallocatechin Gallate: Novel Insights Into Biological Evidence},
  journal = {The Journal of Clinical Hypertension},
  year = {2025},
  volume = {27},
  number = {6},
  doi = {10.1111/jch.70036}
}
Kostenlos starten →